Compare LULU & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LULU | MEDP |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 17.2B |
| IPO Year | 2007 | 2016 |
| Metric | LULU | MEDP |
|---|---|---|
| Price | $94.23 | $615.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 35 | 14 |
| Target Price | $104.91 | ★ $595.92 |
| AVG Volume (30 Days) | ★ 4.5M | 213.4K |
| Earning Date | 09-03-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | 4.59 | ★ 8.53 |
| Revenue | ★ $11,102,600,000.00 | N/A |
| Revenue This Year | N/A | $12.72 |
| Revenue Next Year | N/A | $6.33 |
| P/E Ratio | ★ $20.19 | $70.66 |
| Revenue Growth | ★ 4.86 | N/A |
| 52 Week Low | $90.38 | $373.00 |
| 52 Week High | $225.98 | $677.90 |
| Indicator | LULU | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 53.88 |
| Support Level | N/A | $565.78 |
| Resistance Level | $104.24 | $632.08 |
| Average True Range (ATR) | 2.83 | 18.52 |
| MACD | 0.10 | -1.88 |
| Stochastic Oscillator | 26.80 | 48.05 |
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.